We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nanotechnology Employed to Detect Oral Cancer

By LabMedica International staff writers
Posted on 26 Aug 2010
A new test for oral cancer, which a dentist or oral surgeon could perform by simply using a brush to collect cells from a patient's mouth, has been developed. More...


The test, which could provide a rapid accurate diagnosis for lesions where there is a suspicion of oral cancer. The new test will involve removing cells with a brush, placing them on a chip, and inserting the chip into the analyzer, leading to a result in 8-10 minutes.

This new technology uses the latest techniques in microchip design, nanotechnology, micro-fluids, image analysis, pattern recognition, and biotechnology to shrink many of the main functions of a state-of-the-art clinical pathology laboratory onto a nano-biochip the size of a credit card.

The nano-biochips are disposable and slotted like a credit card into a battery-powered analyzer. A brush-biopsy sample is placed on the card and microfluidic circuits wash cells from the sample into the reaction chamber. The cells pass through minifluidic channels and come in contact with "biomarkers" that react only with specific types of diseased cells. The machine uses two light-emitting diodes (LED's), to light up various regions of the cells and cell compartments. Healthy and diseased cells can be distinguished from one another by the way they glow in response to the LEDs.

A team at the University of Sheffield (Sheffield, UK) begun carrying out clinical trials on patients at Charles Clifford Dental Hospital, (Sheffield, UK) for two years to perfect the technology and make it as sensitive as possible. If the trials confirm that the new technology is as effective as carrying out a biopsy then it could become a regular application at dentist surgeries in the future. The current procedure involves removing a small piece of tissue from the mouth and sending it to a pathologist. This is typically done at a hospital, can take a week or more, and involve extra visits for the patient.

Martin Thornhill, M.BB.S., B.D.S., Ph.D., Professor of Oral Medicine at Sheffield University, said, "This new affordable technology will significantly increase our ability to detect oral cancer in the future. With the new technology, a brush would be used to painlessly remove a few cells from the lining of the mouth that would be analyzed within minutes in the presence of the patient, so that the patient would know the result before leaving the clinic.”

Related Links:

University of Sheffield
Charles Clifford Dental Hospital




Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Microbiology

view channel
Image: EBP and EBP plus have received FDA 510(k) clearance and CE-IVDR Certification for use on the BD COR system (Photo courtesy of BD)

High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample

Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.